Rekombinanter EGFR (Panitumumab Biosimilar) Antikörper
Kurzübersicht für Rekombinanter EGFR (Panitumumab Biosimilar) Antikörper (ABIN7200662)
Target
Antikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
-
-
Verwendungszweck
- Panitumumab Biosimilar, Human EGFR/ErbB-1/HER1 Monoclonal Antibody
-
Spezifität
- The monoclonal antibody panitumumab biosimilar specifically binds to the human EGFR, ErbB-1 and HER1.
-
Produktmerkmale
- Panitumumab, a fully anti-EGFR (epidermal growth factor receptor, EGF receptor, ErbB-1 and HER1 in humans) human monoclonal antibody, is used for the treatment of refractory EGFR-expressing metastatic colorectal cancer in patients with non-mutated (wild-type) KRAS".
-
Aufreinigung
- Protein A or G affinity column
-
Reinheit
- >95 % by reducing SDS-PAGE
-
Sterilität
- 0.2 μm filtered
-
Endotoxin-Niveau
- < 1 EU per 1 mg of the protein by the LAL method
-
Immunogen
- The monoclonal antibody panitumumab biosimilar was produced in the Panitumumab biosimilar CHO stable cell line.
-
Isotyp
- IgG2
-
-
-
-
Applikationshinweise
- ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by panitumumab.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- > 3 mg/mL
-
Buffer
- PBS, pH 7.4, no stabilizers or preservatives.
-
Konservierungsmittel
- Without preservative
-
Lagerung
- 4°C,-20 °C
-
Informationen zur Lagerung
- 12 months from date of receipt, -20 to -70°C as supplied. 1 month from date of receipt, 2 to 8°C as supplied.
-
Haltbarkeit
- 12 months
-
-
- EGFR (Panitumumab Biosimilar)
-
Andere Bezeichnung
- Panitumumab Biosimilar
-
Substanzklasse
- Biosimilar
Target
-